东宝生物

- 300239

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2023  2022  2021  2020  2019  2018  2017  2016  2015  2014 
东宝生物(300239) 利润表
单位:万元
报表日期2023-09-302023-06-302023-03-312022-12-312022-09-30
一、营业总收入73,467.1152,069.8626,131.9594,339.7070,604.37
营业收入73,467.1152,069.8626,131.9594,339.7070,604.37
二、营业总成本61,806.4743,943.5422,098.4181,958.3160,361.49
营业成本53,807.2738,426.1619,439.6470,996.2152,401.35
营业税金及附加964.90700.24331.731,252.32969.41
销售费用1,383.30931.94477.861,783.721,332.44
管理费用3,713.032,588.931,234.305,123.363,750.76
财务费用-36.011.4419.83219.54201.78
研发费用1,973.991,294.82595.072,583.161,705.75
资产减值损失----------
公允价值变动收益----------
投资收益-364.79-238.55-76.30-191.08-71.90
其中:对联营企业和合营企业的投资收益-341.43-235.20-76.30-168.81-48.11
汇兑收益----------
三、营业利润11,893.298,210.814,121.2913,051.4510,749.09
加:营业外收入49.513.701.00168.7964.29
减:营业外支出42.5222.7911.2055.5325.54
其中:非流动资产处置损失----------
四、利润总额11,900.278,191.714,111.0813,164.7110,787.85
减:所得税费用1,707.011,132.43642.361,621.111,543.94
五、净利润10,193.267,059.283,468.7211,543.609,243.91
归属于母公司所有者的净利润9,526.176,500.413,113.7410,943.738,778.46
少数股东损益667.09558.87354.98599.86465.45
六、每股收益
基本每股收益(元/股)0.16050.10950.05250.18440.1479
稀释每股收益(元/股)0.16050.10950.05250.18440.1479
七、其他综合收益----------
八、综合收益总额10,193.267,059.283,468.7211,543.609,243.91
归属于母公司所有者的综合收益总额9,526.176,500.413,113.7410,943.738,778.46
归属于少数股东的综合收益总额667.09558.87354.98599.86465.45
下载全部历史数据到excel中 返回页顶